Unlock stock picks and a broker-level newsfeed that powers Wall Street.
Frankfurt - Delayed Quote EUR

Kenvue Inc. (J4D.F)

Compare
19.75
+0.16
+(0.80%)
At close: 3:29:02 PM GMT+2
Loading Chart for J4D.F
  • Previous Close 19.59
  • Open 19.80
  • Bid --
  • Ask --
  • Day's Range 19.75 - 19.91
  • 52 Week Range 16.08 - 23.50
  • Volume 706
  • Avg. Volume 87
  • Market Cap (intraday) 38.187B
  • Beta (5Y Monthly) --
  • PE Ratio (TTM) 40.30
  • EPS (TTM) 0.49
  • Earnings Date May 5, 2025 - May 9, 2025
  • Forward Dividend & Yield 0.78 (3.71%)
  • Ex-Dividend Date Feb 12, 2025
  • 1y Target Est --

Kenvue Inc. operates as a consumer health company in the United States, Europe, the Middle East, Africa, Asia-Pacific, and Latin America. It operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, eye care, and other products under the Tylenol, Motrin, Benadryl, Nicorette, Zarbee's, ORSLTM, Rhinocort, Calpol, and Zyrtec brands. Its Skin Health and Beauty segment provides face and body care, hair, sun, and other care products under the Neutrogena, Aveeno, Dr.Ci:Labo, Le Petit Marseillais, Lubriderm, Rogaine, and OGX brand names. The Essential Health segment offers oral and baby, women's health, wound, and other care products under the Listerine, Johnson's, Band-Aid, and Stayfree, o.b., tampons, Carefree, and Desitin Diaper Rash brands. Kenvue Inc. was incorporated in 2022 and is headquartered in Summit, New Jersey.

www.kenvue.com

22,000

Full Time Employees

December 29

Fiscal Year Ends

Recent News: J4D.F

View More

Performance Overview: J4D.F

Trailing total returns as of 4/8/2025, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

J4D.F
1.42%
S&P 500 (^GSPC)
15.28%

1-Year Return

J4D.F
12.23%
S&P 500 (^GSPC)
4.22%

3-Year Return

J4D.F
16.46%
S&P 500 (^GSPC)
11.02%

5-Year Return

J4D.F
16.46%
S&P 500 (^GSPC)
81.19%

Compare To: J4D.F

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: J4D.F

View More

Valuation Measures

Annual
As of 4/7/2025
  • Market Cap

    37.89B

  • Enterprise Value

    44.85B

  • Trailing P/E

    39.85

  • Forward P/E

    18.73

  • PEG Ratio (5yr expected)

    2.20

  • Price/Sales (ttm)

    2.68

  • Price/Book (mrq)

    4.25

  • Enterprise Value/Revenue

    3.19

  • Enterprise Value/EBITDA

    19.96

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    6.67%

  • Return on Assets (ttm)

    6.88%

  • Return on Equity (ttm)

    9.87%

  • Revenue (ttm)

    15.45B

  • Net Income Avi to Common (ttm)

    1.03B

  • Diluted EPS (ttm)

    0.49

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    1.07B

  • Total Debt/Equity (mrq)

    90.18%

  • Levered Free Cash Flow (ttm)

    1.62B

Research Analysis: J4D.F

View More

Company Insights: J4D.F

Research Reports: J4D.F

View More